DE69001972D1 - Mittel zum nachweis von gehirnkrankheiten in zusammenhang mit nervenscheidenmarkzerstoerung, insbesondere sklerosis multiplex. - Google Patents

Mittel zum nachweis von gehirnkrankheiten in zusammenhang mit nervenscheidenmarkzerstoerung, insbesondere sklerosis multiplex.

Info

Publication number
DE69001972D1
DE69001972D1 DE9090402399T DE69001972T DE69001972D1 DE 69001972 D1 DE69001972 D1 DE 69001972D1 DE 9090402399 T DE9090402399 T DE 9090402399T DE 69001972 T DE69001972 T DE 69001972T DE 69001972 D1 DE69001972 D1 DE 69001972D1
Authority
DE
Germany
Prior art keywords
vascel
nervous
destruction
marker
media
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE9090402399T
Other languages
English (en)
Other versions
DE69001972T2 (de
Inventor
Jean-Pierre Zanetta
Jean-Marie Warter
Sabine Kuchler
Guy Vincendon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Application granted granted Critical
Publication of DE69001972D1 publication Critical patent/DE69001972D1/de
Publication of DE69001972T2 publication Critical patent/DE69001972T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/285—Demyelinating diseases; Multipel sclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/827—Lectins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/828—Protein A

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Rehabilitation Therapy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Valve Device For Special Equipments (AREA)
  • Steering-Linkage Mechanisms And Four-Wheel Steering (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Air Bags (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Fuses (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steering Control In Accordance With Driving Conditions (AREA)
  • Ignition Installations For Internal Combustion Engines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE9090402399T 1989-09-06 1990-08-30 Mittel zum nachweis von gehirnkrankheiten in zusammenhang mit nervenscheidenmarkzerstoerung, insbesondere sklerosis multiplex. Expired - Fee Related DE69001972T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8911667A FR2651581B1 (fr) 1989-09-06 1989-09-06 Moyens pour le diagnostic de neuropathies demyelinisantes, en particulier de la sclerose en plaques.

Publications (2)

Publication Number Publication Date
DE69001972D1 true DE69001972D1 (de) 1993-07-22
DE69001972T2 DE69001972T2 (de) 1993-09-23

Family

ID=9385190

Family Applications (1)

Application Number Title Priority Date Filing Date
DE9090402399T Expired - Fee Related DE69001972T2 (de) 1989-09-06 1990-08-30 Mittel zum nachweis von gehirnkrankheiten in zusammenhang mit nervenscheidenmarkzerstoerung, insbesondere sklerosis multiplex.

Country Status (14)

Country Link
US (1) US5225352A (de)
EP (1) EP0416984B1 (de)
JP (1) JP3032290B2 (de)
AT (1) ATE90791T1 (de)
AU (1) AU648516B2 (de)
CA (1) CA2024731A1 (de)
DE (1) DE69001972T2 (de)
DK (1) DK0416984T3 (de)
ES (1) ES2057476T3 (de)
FI (1) FI921009A0 (de)
FR (1) FR2651581B1 (de)
IE (1) IE64042B1 (de)
NO (1) NO920852D0 (de)
WO (1) WO1991003737A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2679034A1 (fr) * 1991-07-10 1993-01-15 Centre Nat Rech Scient Determination de la malignite des cellules de tumeurs humaines ou animales, au moyen de lectines endogenes.
FR2689520B1 (fr) * 1992-04-03 1996-07-19 Bio Merieux Procede et milieu de culture pour l'obtention de cellules infectees par un virus associe a la sclerose en plaques.
FR2689521B1 (fr) * 1992-04-03 1996-07-19 Bio Merieux Procede d'obtention et maintien d'une culture cellulaire viable, infectee par un virus associe a la sclerose en plaques, et produits biologiques derives de ladite culture.
ES2233936T3 (es) 1994-02-04 2005-06-16 Bio Merieux Virus msrv1 asociado a la esclerosis en placas, sus constituyentes nucleicos y sus aplicaciones.
FR2716198B1 (fr) * 1994-02-15 1996-04-19 Bio Merieux Facteur cytotoxique tel qu'associé à la sclérose en plaques, sa détection et sa quantification.
US6562629B1 (en) 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6861053B1 (en) * 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
FR2737500B1 (fr) 1995-08-03 1997-08-29 Bio Merieux Materiel viral et fragments nucleotidiques associes a la sclerose en plaques, a des fins de diagnostic, prophylactiques et therapeutiques
US6582703B2 (en) * 1996-11-26 2003-06-24 Bio Merieux Isolated nucleotide sequences associated with multiple sclerosis or rheumatoid arthritis and a process of detecting
JPH11143616A (ja) 1997-11-10 1999-05-28 Sega Enterp Ltd 文字通信装置
WO2000007602A1 (en) * 1998-08-06 2000-02-17 The Johns Hopkins University School Of Medicine Compounds for altering cell surface sialic acids and methods of use therefor
US6762032B1 (en) * 1999-08-23 2004-07-13 Biocrystal, Ltd. Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response
US6899726B2 (en) 2000-10-05 2005-05-31 Seacoast Technologies, Inc. Expandable device for thermal therapy including spiral element
US7858602B2 (en) * 2000-10-16 2010-12-28 Rodriguez Victorio C Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging disorders due to oxidative stress and as growth factors of stem cells
CA2501873A1 (en) * 2002-10-11 2004-04-22 The Regents Of The University Of California A method for diagnosis and prognosis of multiple sclerosis
US6947870B2 (en) * 2003-08-18 2005-09-20 Baker Hughes Incorporated Neural network model for electric submersible pump system
FI20155280A (fi) 2015-04-15 2016-10-16 Medicortex Finland Oy Aivovamman prognostisia ja diagnostisia glykaanipohjaisia biomarkkereita

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311686A (en) * 1979-04-30 1982-01-19 The Immunology Development Corporation Methodology for the immunodiagnosis of multiple sclerosis and/or malignant diseases from blood sample analysis
FR2618439B1 (fr) * 1987-07-21 1990-05-25 Strosberg Arthur Sequences d'amino-acides reproduisant au moins en partie la sequence des lectines animales et humaines, leurs procedes d'obtention, leurs applications diagnostiques et therapeutiques
AU632474B2 (en) * 1988-04-14 1993-01-07 Incyte Pharmaceuticals, Inc. 14-beta-gal mammalian lectins

Also Published As

Publication number Publication date
DE69001972T2 (de) 1993-09-23
WO1991003737A1 (fr) 1991-03-21
JPH05500858A (ja) 1993-02-18
FR2651581A1 (fr) 1991-03-08
IE903190A1 (en) 1991-03-13
AU6421490A (en) 1991-04-08
IE64042B1 (en) 1995-06-28
NO920852L (no) 1992-03-04
FR2651581B1 (fr) 1994-05-13
US5225352A (en) 1993-07-06
ES2057476T3 (es) 1994-10-16
EP0416984A1 (de) 1991-03-13
DK0416984T3 (da) 1993-08-16
JP3032290B2 (ja) 2000-04-10
AU648516B2 (en) 1994-04-28
CA2024731A1 (fr) 1991-03-07
ATE90791T1 (de) 1993-07-15
FI921009A0 (fi) 1992-03-06
EP0416984B1 (de) 1993-06-16
NO920852D0 (no) 1992-03-04

Similar Documents

Publication Publication Date Title
DE69001972D1 (de) Mittel zum nachweis von gehirnkrankheiten in zusammenhang mit nervenscheidenmarkzerstoerung, insbesondere sklerosis multiplex.
ATE165395T1 (de) Inhibitoren des tumorwachstums aus geweben, methoden ihrer herstellung und verwendungen
ES2094733T3 (es) Deteccion de enfermedades o disfunciones neurologicas.
TR24305A (tr) Blok kopolimer, bunu yapma metodu, bunun diamin oencueleri, bu tip diaminleri yapm
ES2036737T3 (es) Procedimiento para la obtencion de mezclas farmaceuticas.
BR8307353A (pt) Compostos de tri(pireridilaminotriazilamino),sua preparacao e sua utilizacao como estabilizadores de polimeros
NO904291D0 (no) Fremgangsmaate for fremstilling av radiomerkede antikoagulerende peptider.
GR3036138T3 (en) A screening method for identifying ligands for target proteins
DK0948604T3 (da) Screeningsmetoder for forbindelser som binder til PYK2-polypeptidet
SE8403630L (sv) Humana proteiner
ATE417930T1 (de) Proteinkinase npk-110
IT8919241A0 (it) Glicoconiugati anfifilici sintetici per impiego neurologico.
DE69016071D1 (de) Verfahren zur Augen-Diagnostik.
DK0764273T3 (da) Alfa B crystallin til anvendelse i diagnose og terapi af autoimmune sygdomme, især multipel sklerose
ES2176523T3 (es) Procedimiento para la deteccion de la enfermedad de alzheimer.
DE69015372D1 (de) Protein-testverfahren.
DE69001039D1 (de) Nichtalkalisches suessen von kohlenwasserstofffraktionen.
IT8921128A0 (it) Metodo per la determinazione della attivita' funzionale della proteina s nel plasma umano.
FI844645A0 (fi) 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar.
DE69009394D1 (de) Verfahren zur Herstellung von 3-Cyano-3,5,5-trimethyl-1-cyclohexanon.
ATE312914T1 (de) Rdgb-proteine
DE69009592D1 (de) Vorrichtung zur gegenseitigen Ausrichtung von verschieden farbigen Strahlbündeln und Visiereinrichtung, die diese Vorrichtung enthält.
BR8304513A (pt) Composto,processo para sua preparacao,e fibra de poliester ou poliamida
PT88913A (pt) Processo para a preparacao da proteina pp4-x anticoagulante
ATE109124T1 (de) Verfahren zur enantiomerentrennung von benzopyranderivaten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee